Allouche Cyril 4
4 · Revance Therapeutics, Inc. · Filed Jun 22, 2018
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Award
Common Stock
2018-06-20+250→ 4,750 total - Award
Employee Stock Option (Right to Buy)
2018-06-20+9,500→ 9,500 totalExercise: $30.75Exp: 2028-06-19→ Common Stock (9,500 underlying)
Footnotes (2)
- [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from July 15, 2018, subject to Mr. Allouche's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan ("the Plan")) on each vesting date.
- [F2]The shares subject to the option shall vest as follows: 1/48th of the total number of shares subject to the Option shall vest in 48 equal monthly installments over 4 years following June 20, 2018, subject to Reporting Person's Continuous Service (as defined in the Plan) as of such date.